Seth Klarman Jazz Pharmaceuticals PLC Transaction History

Baupost Group LLC

  • $3.52 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$103.94 - $118.98 $45.8 Million - $52.4 Million
440,552 Added 52.84%
1,274,248 $136 Million
Q4 2023

Feb 13, 2024
BUY
$114.26 - $136.0 $18.3 Million - $21.8 Million
160,000 Added 23.75%
833,696 $103 Million
Q2 2023

Aug 11, 2023
BUY
$122.5 - $147.16 $23.9 Million - $28.7 Million
195,000 Added 40.74%
673,696 $83.5 Million
Q1 2023

May 12, 2023
BUY
$133.98 - $160.47 $64.1 Million - $76.8 Million
478,696 New
478,696 $70 Million

Others Institutions Holding JAZZ

# of Institutions
512
Shares Held
57.5M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track Seth Klarman's Portfolio

Track Seth Klarman Portfolio

Follow Seth Klarman (Baupost Group LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baupost Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baupost Group LLC and Seth Klarman with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email